Inventor · disambiguated record
Piaoyang Sun
Also filed as: SUN PIAOYANG
43 granted patents·9 pending applications·90 citations·filing 2005–2022
96Inventor score
Files withJIANGSU HENGRUI MEDICINE CO23Shanghai hengrui pharmaceutical co ltd9SUN PIAOYANG6SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD4SHANGHAI SENHUI MEDICINE CO LTD2
Top patents by PatentIndex Score
52 records- 0194US10905743B2Interleukin 15 protein complexJIANGSU HENGRUI MEDICINE CO·Filed 2015·Granted Feb 2, 2021·9 cites·10 claims
- 0291US11717559B2Interleukin 15 protein complex and use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2020·Granted Aug 8, 2023·2 cites·15 claims
- 0389US10786567B2Stable anti-PD-1 antibody pharmaceutical preparation and application thereof in medicineSUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD·Filed 2016·Granted Sep 29, 2020·4 cites·18 claims
- 0489US10023577B2Crystalline form of JAK kinase inhibitor bisulfate and a preparation method thereofJIANGSU HENGRUI MEDICINE CO·Filed 2015·Granted Jul 17, 2018·6 cites·19 claims
- 0585US9586947B2Imidazoline derivatives, preparation methods thereof, and their applications in medicineShanghai hengrui pharmaceutical co ltd·Filed 2013·Granted Mar 7, 2017·9 cites·21 claims
- 0685US9422300B2Bisulfate of janus kinase (JAK) inhibitor and preparation method thereforJIANGSU HENGRUI MEDICINE CO·Filed 2014·Granted Aug 23, 2016·9 cites·9 claims
- 0783US10815304B2PD-L1 antibody, antigen-binding fragment thereof and medical application thereofSUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD·Filed 2016·Granted Oct 27, 2020·3 cites·25 claims
- 0883US10150770B2Crystal form of bisulfate of JAK inhibitor and preparation method thereforJIANGSU HENGRUI MEDICINE CO·Filed 2015·Granted Dec 11, 2018·6 cites·17 claims
- 0981US10442793B2Oxa spiro derivative, preparation method therefor, and applications thereof in medicinesJIANGSU HENGRUI MEDICINE CO·Filed 2016·Granted Oct 15, 2019·2 cites·24 claims
- 1080US8183242B2Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereofSUN PIAOYANG·Filed 2005·Granted May 22, 2012·14 cites·27 claims
- 1179US9388133B2Pyrrole sulfonamide derivative, preparation method for same, and medical application thereofJIANGSU HANSOH PHARMACEUTICAL CO LTD·Filed 2013·Granted Jul 12, 2016·5 cites·21 claims
- 1276US9637484B2Cycloalkyl acid derivative, preparation method thereof, and pharmaceutical application thereofShanghai hengrui pharmaceutical co ltd·Filed 2014·Granted May 2, 2017·5 cites·20 claims
- 1376US9309226B2Crystalline form I of tyrosine kinase inhibitor dimaleate and preparation methods thereofJIANGSU HENGRUI MEDICINE CO·Filed 2013·Granted Apr 12, 2016·3 cites·14 claims
- 1476US8362256B2Salts of N-[4-(1-cyanocyclopentyl)phenyl]-2-(4-pyridylmethyl)amino-3-pyridinecarboxamideJIANGSU HENGRUI MEDICINE CO·Filed 2009·Granted Jan 29, 2013·3 cites·4 claims
- 1574US8541405B2Methods for the preparation of Ivabradine sulfate and form I crystal thereofSUN PIAOYANG·Filed 2009·Granted Sep 24, 2013·2 cites·17 claims
- 1673US10364234B2Pyridinecarboxamide derivatives, preparation method thereof and pharmaceutical uses thereofJIANGSU HENGRUI MEDICINE CO·Filed 2015·Granted Jul 30, 2019·1 cites·16 claims
- 1773US10005781B2Pyrazolopyrimidone or pyrrolotriazone derivatives, method of preparing same, and pharmaceutical applications thereofShanghai hengrui pharmaceutical co ltd·Filed 2014·Granted Jun 26, 2018·2 cites·20 claims
- 1873US9862765B2IL-17A binding agent and uses thereofShanghai hengrui pharmaceutical co ltd·Filed 2014·Granted Jan 9, 2018·2 cites·25 claims
- 1969US11981733B2LAG-3 antibody, antigen-binding fragment thereof, and pharmaceutical application thereofJIANGSU HENGRUI MEDICINE CO·Filed 2021·Granted May 14, 2024·0 cites·20 claims
- 2067US10759788B2Pharmaceutical uses of pyridine carboxamide derivativesJIANGSU HENGRUI MEDICINE CO·Filed 2019·Granted Sep 1, 2020·0 cites·12 claims
- 2167US8518946B2Salts of (R)-7-[3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-trifluoromethyl-5,6,7,8-tetrahydroimidazo[1,5-a] pyrazine-1-carboxylic acid, preparation method and medical use thereofTANG PENG CHO·Filed 2011·Granted Aug 27, 2013·1 cites·5 claims
- 2263US10442794B2Processes for preparing pyridine carboxamide derivativesJIANGSU HENGRUI MEDICINE CO·Filed 2019·Granted Oct 15, 2019·0 cites·20 claims
- 2362US11155617B2LAG-3 antibody, antigen-binding fragment thereof, and pharmaceutical application thereofJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Oct 26, 2021·0 cites·21 claims
- 2461US8338471B2(2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides as metalloproteinase inhibitorsWALLBERG HANS·Filed 2011·Granted Dec 25, 2012·1 cites·9 claims
- 2560US10857146B2Method for preventing or treating tumor diseases with a combination of tyrosine kinase inhibitor and CDK4/6 inhibitorJIANGSU HENGRUI MEDICINE CO·Filed 2019·Granted Dec 8, 2020·0 cites·12 claims
- 2660US10633388B2Pyrazolopyrimidone derivatives and methods of use thereofShanghai hengrui pharmaceutical co ltd·Filed 2019·Granted Apr 28, 2020·0 cites·21 claims
- 2760US9321779B2Intermediate for synthesizing caspofungin and preparation method thereofZHANG FUYAO·Filed 2012·Granted Apr 26, 2016·1 cites·21 claims
- 2859US11780923B2PD-L1 antibody, antigen-binding fragment thereof and medical application thereofSUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD·Filed 2020·Granted Oct 10, 2023·0 cites·23 claims
- 2959US2021000954A1Stable anti-pd-1 antibody pharmaceutical preparation and application thereof in medicineSUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 3054US10344034B2Pyrazolopyrimidone or Pyrrolotriazone derivatives, method of preparing same, and pharmaceutical applications thereofShanghai hengrui pharmaceutical co ltd·Filed 2018·Granted Jul 9, 2019·0 cites·11 claims
- 3153US2022267432A1Method for treating autoimmune disease by il-17 antagonistJIANGSU HENGRUI MEDICINE CO·Filed 2020·Application pending·0 cites
- 3252US8198485B2Resolution of 4,5-dimethoxy-1-(methylaminomenthyl)-benzocyclobutaneSUN PIAOYANG·Filed 2008·Granted Jun 12, 2012·0 cites·25 claims
- 3351US10793643B2PCSK9 antibody, antigen-binding fragment thereof, and medical application thereofJIANGSU HENGRUI MEDICINE CO·Filed 2016·Granted Oct 6, 2020·0 cites·24 claims
- 3451US8921416B2Dronedarone solid dispersion and preparation method thereofSUN PIAOYANG·Filed 2011·Granted Dec 30, 2014·0 cites·18 claims
- 3551US8022092B2(2,5-dioxoimidazolidin-1-yl)-N-hydroxy-acetamides as metalloproteinase inhibitorsMEDIVIR AB·Filed 2006·Granted Sep 20, 2011·0 cites·21 claims
- 3650US8580997B2Process for preparing R-beta-amino phenylbutyric acid derivativesSUN PIAOYANG·Filed 2009·Granted Nov 12, 2013·0 cites·28 claims
- 3747US9895355B2Methods of treating androgen receptor-mediated disorders with imidazoline derivativesShanghai hengrui pharmaceutical co ltd·Filed 2017·Granted Feb 20, 2018·0 cites·9 claims
- 3845US11000518B2Use of combination of VEGFR inhibitor and PARP inhibitor in preparation of medicament for treating gastric cancerJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted May 11, 2021·0 cites·5 claims
- 3945US2010210640A1Benzamide derivatives, their preparation and uses in medicine thereofJIANGSU HENGRUI MEDICINE CO·Filed 2008·Application pending·0 cites
- 4044US2020030453A1Method for preparing antibody-drug conjugateJIANGSU HENGRUI MEDICINE CO·Filed 2018·Application pending·0 cites
- 4142US10301344B2L-proline complex of sodium-glucose cotransporter 2 inhibitor, monohydrate and crystal form thereofJIANGSU HENGRUI MEDICINE CO·Filed 2015·Granted May 28, 2019·0 cites·17 claims
- 4241US8476272B2Pharmaceutical composition for treatment of type 2 diabetesYUAN KAIHONG·Filed 2010·Granted Jul 2, 2013·0 cites·22 claims
- 4340US9458219B2Human insulin analogue and acylated derivative thereofShanghai hengrui pharmaceutical co ltd·Filed 2012·Granted Oct 4, 2016·0 cites·23 claims
- 4439US10398689B2Benzopiperidine derivative, preparation method thereof and medical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2016·Granted Sep 3, 2019·0 cites·24 claims
- 4539US2020270365A1Pcsk9 antibody, antigen-binding fragment thereof, and medical uses thereofJIANGSU HENGRUI MEDICINE CO·Filed 2016·Application pending·0 cites
- 4637US8362240B2Taxol derivatives with antitumor activitySHANGHAI HENGRUI PHARM CO LTD·Filed 2007·Granted Jan 29, 2013·0 cites·8 claims
- 4737US2019315886A1Thrombin antibody, antigen-binding fragment and pharmaceutical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2017·Application pending·0 cites
- 4837US2024190896A1Smtp-7 derivative and use thereofSHANGHAI SENHUI MEDICINE CO LTD·Filed 2022·Application pending·0 cites
- 4936US12492166B2Sulfonylurea derivative and medical uses thereofSHANGHAI SENHUI MEDICINE CO LTD·Filed 2021·Granted Dec 9, 2025·0 cites·18 claims
- 5036US2013005730A1Novel 1,3-oxazolidine compounds and their use as renin inhibitorsSUN PIAOYANG·Filed 2010·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →